Početna › Bolesti probavnog sustava › Texas
Kliničke studije za Bolesti probavnog sustava u državi Texas
13 studija za Bolesti probavnog sustava traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
- Houston8 studija
- San Antonio5 studija
- Tyler5 studija
- Austin4 studija
- Dallas4 studija
- Lewisville4 studija
- Fort Worth3 studija
- El Paso3 studija
- Amarillo3 studija
Službeni tekst studije (engleski)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06598943Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Texas Oncology - West Texas, Abilene
- Texas Oncology - West Texas, Amarillo
- Texas Oncology - Gulf Coast, Beaumont
- i još 27
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07222800Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- Texas Liver Institute, San Antonio
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT07654283Product Surveillance Registry
- Austin
- Dallas
- Fort Worth
- i još 6
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 18. ruj 2026. · NCT01524276Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
- Baylor College of Medicine/Texas Children's Hospital, Austin
- Baylor College of Medicine / Texas Children's Hospital, Houston
U tijeku regrutacija
Od 7 do 12 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT07222943A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- i još 30
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- i još 21
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06419374Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
- University of Texas Health Science Center at Houston, Houston
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07351071Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 10. lip 2026. · NCT07494318Evaluation of Hepato-Pancreato-Biliary
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Oba spola · Ažurirano 10. lip 2026. · NCT07565454GpCRC Pediatric Gastroparesis Registry 2
- Texas Tech University Health Science Center, El Paso
- Baylor College of Medicine/Texas Children's Hospital, Houston
U tijeku regrutacijaOpažajna studija
Od 8 do 25 godina · Oba spola · Ažurirano 3. tra 2026. · NCT05981300Gastroparesis Registry 4
- Texas Tech University Health Science Center (TTUHSC), El Paso
U tijeku regrutacijaOpažajna studija
Od 18 do 85 godina · Oba spola · Ažurirano 3. tra 2026. · NCT05846802Endoscopic Retrograde Cholangiopancreatography
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
U tijeku regrutacijaOpažajna studija
Od 15 godina i više · Oba spola · Ažurirano 24. ožu 2026. · NCT07490132Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.